Created at:1/13/2025
Belimumab is a prescription medication that helps calm your overactive immune system when it mistakenly attacks your own body. It's specifically designed to treat autoimmune conditions like lupus, where your immune system needs gentle guidance to stop fighting against you.
This medication works by blocking a protein called BLyS (B-lymphocyte stimulator) that tells certain immune cells to become overactive. Think of it as turning down the volume on an immune system that's been playing too loudly.
Belimumab is primarily used to treat systemic lupus erythematosus (SLE), commonly known as lupus. Your doctor might prescribe it when you have active lupus that hasn't responded well enough to standard treatments like antimalarials, corticosteroids, or immunosuppressants.
The medication is also approved for treating lupus nephritis, which happens when lupus affects your kidneys. This is a more serious form of lupus that needs careful management to protect your kidney function.
Additionally, belimumab can help with active systemic lupus erythematosus in children aged 5 years and older. Your doctor will carefully weigh the benefits and risks before recommending it for younger patients.
Belimumab works by targeting B-cells, which are immune cells that produce antibodies. In lupus, these B-cells become overactive and create antibodies that attack your own healthy tissues instead of protecting you from infections.
The medication blocks BLyS, a protein that acts like fuel for these overactive B-cells. By reducing this fuel source, belimumab helps decrease the number of problematic B-cells in your system, which can reduce lupus symptoms and flares.
This is considered a targeted therapy rather than a broad immunosuppressant, meaning it's more precise in how it affects your immune system. However, it's still a strong medication that requires careful monitoring by your healthcare team.
Belimumab comes in two forms: intravenous (IV) infusion and subcutaneous (under-the-skin) injection. Your doctor will determine which form is best for you based on your specific condition and lifestyle needs.
For IV infusions, you'll receive the medication at a healthcare facility every four weeks. The infusion typically takes about one hour, and you'll be monitored during and after the treatment for any immediate reactions.
If you're using the subcutaneous form, you'll likely inject it once weekly at home after proper training. Your healthcare team will teach you the correct injection technique and help you feel comfortable with the process.
You don't need to take belimumab with food, but it's important to maintain a consistent schedule. Some people find it helpful to mark their calendar or set phone reminders to stay on track.
Belimumab is typically a long-term treatment that you'll continue as long as it's helping your lupus and you're tolerating it well. Many people take it for years to maintain control of their symptoms and prevent flares.
You might start noticing improvements after a few months, though it can take up to six months to see the full benefits. This gradual improvement happens because belimumab works by slowly reducing the overactive immune cells rather than providing immediate relief.
Your doctor will regularly assess how well the medication is working through blood tests, symptom monitoring, and checking for any side effects. They'll help you decide when it's appropriate to continue, adjust, or potentially stop the treatment.
Like all medications that affect your immune system, belimumab can cause side effects, though not everyone experiences them. Being aware of what to watch for helps you stay safe and get prompt care if needed.
The most common side effects you might experience include nausea, diarrhea, fever, stuffy nose, bronchitis, insomnia, and pain in your arms or legs. These symptoms are usually mild and often improve as your body adjusts to the medication.
More serious but less common side effects can include:
Because belimumab affects your immune system, you'll have a higher risk of getting infections. This means you should contact your doctor if you develop fever, flu-like symptoms, or any signs of infection.
Rare but serious side effects include severe depression, thoughts of self-harm, progressive multifocal leukoencephalopathy (PML), and reactivation of hepatitis B in people who previously had this infection.
Belimumab isn't right for everyone, and your doctor will carefully review your medical history before prescribing it. You shouldn't take this medication if you've had a severe allergic reaction to belimumab or any of its ingredients in the past.
People with active, severe infections should wait until the infection is fully treated before starting belimumab. This includes serious bacterial, viral, fungal, or other infections that could worsen with immune suppression.
Your doctor will be especially cautious if you have:
If you're pregnant or planning to become pregnant, you'll need to discuss the risks and benefits with your doctor. Belimumab can cross the placenta and potentially affect your developing baby's immune system.
Belimumab is available under the brand name Benlysta. This is the only brand name currently available for this medication, manufactured by GSK (GlaxoSmithKline).
Whether you receive the IV or subcutaneous form, both are marketed under the same Benlysta brand name. Your prescription will specify which formulation and strength you need.
If belimumab isn't suitable for you or isn't providing adequate control of your lupus, several alternative treatments are available. Your doctor might consider other biologic medications like rituximab, which also targets B-cells but works differently.
Traditional immunosuppressive medications remain important options, including methotrexate, mycophenolate, azathioprine, and cyclophosphamide. These medications have longer track records and may be more appropriate for certain situations.
Newer treatments like anifrolumab (Saphnelo) offer another targeted approach for lupus treatment. Your doctor will consider factors like your specific symptoms, previous treatments, and overall health when selecting the best option for you.
Sometimes, combination therapy with antimalarials like hydroxychloroquine or careful corticosteroid management might be more appropriate than switching to a different biologic medication.
Comparing belimumab to rituximab isn't straightforward because they work differently and are used in different situations. Both target B-cells, but rituximab depletes these cells more completely while belimumab reduces their activation more gradually.
Belimumab has more robust clinical trial data specifically for lupus treatment, with FDA approval based on large, well-designed studies. Rituximab, while effective for many lupus patients, is used "off-label" for this condition.
The choice between these medications depends on your specific situation, including how severe your lupus is, which organs are affected, and how you've responded to previous treatments. Your doctor will consider your individual factors rather than declaring one universally "better."
Some people do well with belimumab's gentler, sustained approach, while others need rituximab's more dramatic B-cell depletion. Both medications require careful monitoring and have their own unique side effect profiles.
Q1:Is Belimumab Safe for People with Kidney Disease?
Belimumab is actually approved for treating lupus nephritis, which is kidney involvement from lupus. However, if you have severe kidney disease from other causes, your doctor will need to carefully evaluate whether belimumab is appropriate for you.
The medication is primarily eliminated through your body's natural protein breakdown processes rather than through kidney filtration, so mild to moderate kidney problems usually don't require dose adjustments. Your doctor will monitor your kidney function regularly regardless.
Q2:What Should I Do If I Accidentally Use Too Much Belimumab?
If you accidentally inject more subcutaneous belimumab than prescribed, contact your doctor or healthcare provider immediately. While there's no specific antidote for belimumab overdose, they'll want to monitor you more closely for side effects.
For IV infusions, overdose is less likely since healthcare professionals administer the medication. However, if you suspect an error occurred during your infusion, inform your healthcare team right away so they can take appropriate monitoring steps.
Q3:What Should I Do If I Miss a Dose of Belimumab?
If you miss a subcutaneous injection, take it as soon as you remember, then return to your regular weekly schedule. Don't double up on doses to make up for a missed one.
For IV infusions, contact your healthcare provider to reschedule as soon as possible. Try to maintain the four-week interval between doses, but don't worry if you need to adjust by a few days due to scheduling constraints.
Q4:When Can I Stop Taking Belimumab?
Never stop taking belimumab without discussing it with your doctor first. Stopping suddenly could lead to lupus flares or worsening of your symptoms, as the medication's protective effects gradually wear off.
Your doctor might consider stopping belimumab if you've achieved stable remission for an extended period, if you're experiencing intolerable side effects, or if the medication isn't providing adequate benefit. They'll help you transition safely to other treatments if needed.
Q5:Can I Get Vaccines While Taking Belimumab?
You should avoid live vaccines while taking belimumab, as they could potentially cause infections in people with suppressed immune systems. This includes vaccines like MMR, varicella (chickenpox), and nasal flu vaccines.
Inactivated vaccines (like the flu shot, COVID-19 vaccines, and pneumonia vaccine) are generally safe and recommended. However, they might not work as well while you're taking belimumab, so discuss timing and expectations with your doctor.